1301P Sequential therapy of metastatic pancreatic ductal adenocarcinoma (PDAC) after failure of gemcitabine plus nab-paclitaxel with either 5-FU/folinic acid (5FU/LV) plus irinotecan (FOLFIRI) followed by 5FU/LV plus oxaliplatin (OFF) or the reverse sequence: The PANTHEON trial (AIO PAK 0116)
Saved in:
| Title: | 1301P Sequential therapy of metastatic pancreatic ductal adenocarcinoma (PDAC) after failure of gemcitabine plus nab-paclitaxel with either 5-FU/folinic acid (5FU/LV) plus irinotecan (FOLFIRI) followed by 5FU/LV plus oxaliplatin (OFF) or the reverse sequence: The PANTHEON trial (AIO PAK 0116) |
|---|---|
| Authors: | Modest, D.P.1 (AUTHOR), Heinemann, V.2 (AUTHOR), Schütt, P.3 (AUTHOR), Angermeier, S.4 (AUTHOR), Haberkorn, M.5 (AUTHOR), Waidmann, O.6 (AUTHOR), Graeven, U.7 (AUTHOR), Wille, K.8 (AUTHOR), Kunzmann, V.9 (AUTHOR), Henze, L.10 (AUTHOR), Constantin, C.11 (AUTHOR), De Wit, M.12 (AUTHOR), Denzlinger, C.13 (AUTHOR), Kurreck, A.1 (AUTHOR), Alig, A.H.S.1 (AUTHOR), Stahler, A.1 (AUTHOR), Pelzer, U.1 (AUTHOR), Stintzing, S.1 (AUTHOR), Oettle, H.14 (AUTHOR) |
| Source: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1139-S1139. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 159078200 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1301P Sequential therapy of metastatic pancreatic ductal adenocarcinoma (PDAC) after failure of gemcitabine plus nab-paclitaxel with either 5-FU/folinic acid (5FU/LV) plus irinotecan (FOLFIRI) followed by 5FU/LV plus oxaliplatin (OFF) or the reverse sequence: The PANTHEON trial (AIO PAK 0116) – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Modest%2C+D%2EP%2E%22">Modest, D.P.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Heinemann%2C+V%2E%22">Heinemann, V.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schütt%2C+P%2E%22">Schütt, P.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Angermeier%2C+S%2E%22">Angermeier, S.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Haberkorn%2C+M%2E%22">Haberkorn, M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Waidmann%2C+O%2E%22">Waidmann, O.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Graeven%2C+U%2E%22">Graeven, U.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wille%2C+K%2E%22">Wille, K.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kunzmann%2C+V%2E%22">Kunzmann, V.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Henze%2C+L%2E%22">Henze, L.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Constantin%2C+C%2E%22">Constantin, C.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22De+Wit%2C+M%2E%22">De Wit, M.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Denzlinger%2C+C%2E%22">Denzlinger, C.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kurreck%2C+A%2E%22">Kurreck, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alig%2C+A%2EH%2ES%2E%22">Alig, A.H.S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stahler%2C+A%2E%22">Stahler, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pelzer%2C+U%2E%22">Pelzer, U.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stintzing%2C+S%2E%22">Stintzing, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oettle%2C+H%2E%22">Oettle, H.</searchLink><relatesTo>14</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2022 Supplement 7, Vol. 33, pS1139-S1139. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=159078200 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2022.07.1433 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S1139 Titles: – TitleFull: 1301P Sequential therapy of metastatic pancreatic ductal adenocarcinoma (PDAC) after failure of gemcitabine plus nab-paclitaxel with either 5-FU/folinic acid (5FU/LV) plus irinotecan (FOLFIRI) followed by 5FU/LV plus oxaliplatin (OFF) or the reverse sequence: The PANTHEON trial (AIO PAK 0116) Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Modest, D.P. – PersonEntity: Name: NameFull: Heinemann, V. – PersonEntity: Name: NameFull: Schütt, P. – PersonEntity: Name: NameFull: Angermeier, S. – PersonEntity: Name: NameFull: Haberkorn, M. – PersonEntity: Name: NameFull: Waidmann, O. – PersonEntity: Name: NameFull: Graeven, U. – PersonEntity: Name: NameFull: Wille, K. – PersonEntity: Name: NameFull: Kunzmann, V. – PersonEntity: Name: NameFull: Henze, L. – PersonEntity: Name: NameFull: Constantin, C. – PersonEntity: Name: NameFull: De Wit, M. – PersonEntity: Name: NameFull: Denzlinger, C. – PersonEntity: Name: NameFull: Kurreck, A. – PersonEntity: Name: NameFull: Alig, A.H.S. – PersonEntity: Name: NameFull: Stahler, A. – PersonEntity: Name: NameFull: Pelzer, U. – PersonEntity: Name: NameFull: Stintzing, S. – PersonEntity: Name: NameFull: Oettle, H. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2022 Supplement 7 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 33 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
